On December 22, 2024, the first BIOV International Summit on Life Sciences and Regenerative Medicine, hosted by the AVZ Foundation and BioV Biotechnology Company, was grandly held in Bangkok, Thailand. This summit gathered top scholars, entrepreneurs, and industry leaders from the global life sciences field, focusing on the latest research achievements and future development directions in regenerative medicine and life sciences. Over a hundred guests participated, including Thai royal family members, Nobel Prize winner Professor George F. Smoot, Professor Edvard Moser (online), and Professor Thomas C. Sudhof (online).
The Thai royal family member spoke: Highlighting the importance of international cooperation
A member of the Thai royal family delivered the opening speech, warmly welcoming all professors and guests to gather in Bangkok. He fully recognized the achievements of the global medical community in the field of regenerative medicine and emphasized the importance of international cooperation in promoting the advancement of life sciences, hoping to contribute to global healthcare through this summit.
AVZ Foundation: Using Capital to Promote Innovation in Life Sciences
Ms. Viviana, CEO of the AVZ Foundation, delivered a speech in both Chinese and English at the opening ceremony, warmly welcoming the support of the guests on behalf of the AVZ Foundation and BIOV Biotechnology Company. She pointed out that the life sciences are at the forefront of solving major human challenges, and the universalization of science and technology is a key goal. The AVZ Foundation has always adhered to the concept of innovation-driven development, connecting global resources through capital to support disruptive technologies and business development. She also announced that the foundation will launch more creative programs related to charity in the future, investing part of the profits into scientific research to contribute to human health.
Professor George F. Smoot: The Future Possibilities of Stem Cells
Nobel Prize winner in Physics and 'Father of Stem Cells' Professor George F. Smoot delivered an academic speech titled 'Stem Cell Centers and the Automation and Safety of Treatment'. He analyzed the vast space of the stem cell market from a global treatment layout perspective and reviewed the important achievements in stem cell research. He posed a key question to the attendees: What kind of transformation will stem cells bring in the future? Professor Smoot expressed that it was significant to be present on Christmas Eve and share insights with experts and scholars from various fields.
Professor Edvard Moser: Cell Research and the Treatment Prospects for Alzheimer’s Disease
Nobel Prize winner in Physiology or Medicine Professor Edvard Moser focused his speech on the importance of cell research in the treatment of Alzheimer’s disease. He pointed out that Alzheimer’s disease is particularly common among the elderly, and the research on cell localization systems is of profound significance for overcoming this challenge.
Professor Thomas C. Sudhof: The Broad Applications of Stem Cell-Derived Technologies
Nobel Prize winner Professor Thomas C. Sudhof deeply explored the potential of stem cell-derived cells as tools for understanding diseases. He stated that these technologies may be widely applied in regenerative medicine in the future, providing new pathways to solve major health issues in society.
Dr. Yan Ying: The Application of TILS Cells in Advanced Colorectal Cancer
Dr. Yan Ying from Fudan University School of Medicine shared the preparation of TILS cells and their groundbreaking progress in the clinical application of advanced colorectal cancer. He elaborated on three milestone achievements in tumor research, providing new possibilities and perspectives for cell therapy.
Dr. Chen Lin: Ensuring the Safety and Stability of NK Cell Culture
Dr. Chen Lin, a PhD from Boston University and a postdoctoral researcher at Harvard University, focused his speech on the application of trophoblast cell methods in NK cell culture. He pointed out that scientific verification shows NK cells have good safety and no tumorigenic risk, providing a reliable foundation for future cell therapies.
Dr. Shi Lin: Cell Therapy Opens a New Era in Medicine
Dr. Shi Lin from Queen Mary University of London and the Beijing Novogene Genome Research Center stated that the 20th century was the era of drug therapy, while the 21st century is the era of cell therapy. He showcased the broad prospects of cell therapy in the medical field through numerous examples and defined it as a new star in biomedicine.
Chairman Sun Xin: The Construction of the Health Island Concept
Chairman Sun Xin of Zhongjian Group proposed the concept of a 'Health Island', emphasizing the creation of a comprehensive health management system within the BIOV ecosystem through new products and technologies, opening new models for human health.
Dr. Ma Lixin: Cell Technology Aiding the Cure of Chronic Diseases and Malignant Tumors
Dr. Ma Lixin, a medical doctor from Tongji University, summarized the practical cases of BioV Biotechnology in the clinical cure of chronic diseases and malignant tumors. He emphasized that modern cell technology not only treats diseases but also extends life, bringing new breakthroughs to medical research.
Chairman of the AVZ Foundation's summary speech: Conveying beliefs for the future
Finally, Mr. Yu, chairman of the AVZ Foundation, delivered a concluding speech. He expressed gratitude for the support of the guests and conveyed a firm belief in the future development of life sciences. Mr. Yu stated that the AVZ Foundation will continue to promote international cooperation and contribute to the development of regenerative medicine and life sciences.
This summit provided a high-level communication platform for the global life sciences field, further highlighting the important role of the BIOV project in global health.